RELATIVE BIOAVAILABILITY AND BIOEQUIVALENCE OF THREE DIFFERENT ORAL FORMULATION...

• Author(s): Nunes, Teresa ; Falcão, Amilcar ; Almeida, Luís ; Lima, Ricardo ; Tavares, Susana ; Neta, Carla ; Fontes-Ribeiro, Carlos ; Macedo, Tice ; Soares-da-Silva, Patricio
• Date: 2005
• Persistent ID: http://hdl.handle.net/10316/2811
• Origin: Estudo Geral - Universidade de Coimbra
• Subject(s): eslicarbazepine acetate; bioequivalence; bioavailability
• Document Type: Article
• Language: English

Description

To investigate the bioavailability and bioequivalence of three formulations of eslicarbazepine acetate: 50 mg/mL oral suspension (Test 1), 200 mg tablets (Test 2) and 800 mg tablets (Reference) AES Proceedings of the Annual Meeting of the American Epilepsy Society